Incidence of Cardiovascular Risk Factors in an Indian Urban Cohort Results From the New Delhi Birth Cohort by Huffman, Mark D. et al.
from
●
C
G
j
l
r
e
r
p
f
d
a
l
i
w
h
baround the world
focus on India
Incidence of Cardiovascular Risk Factors
in an Indian Urban Cohort
Results From the New Delhi Birth Cohort
Mark D. Huffman, MD, MPH,*† Dorairaj Prabhakaran, MD, DM, MSC,* Clive Osmond, PHD,‡
Caroline H. D. Fall, DM,‡ Nikhil Tandon, MD, PHD,§ Ramakrishnan Lakshmy, PHD,§
Siddharth Ramji, MD, Anita Khalil, MD,¶ Tarun Gera, MD,# Poornima Prabhakaran, MBBS, MSC,**
S. K. Dey Biswas, MSTAT, MBA,†† K. Srinath Reddy, MD, DM, MSC,§‡‡
Santosh K. Bhargava, MD, DCH,# Harshpal S. Sachdev, MD,§§ on behalf of the New Delhi Birth Cohort
*Centre for Chronic Disease Control, New Delhi, India;
†Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine,
hicago, Illinois;
‡Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton
eneral Hospital, Southampton, United Kingdom;
§All India Institute of Medical Sciences, New Delhi, India;
Department of Pediatrics, Maulana Azad Medical College, New Delhi, India;
¶The Heart Centre, New Delhi, India;
#Department of Pediatrics, Sunder Lal Jain Hospital, New Delhi, India;
**Initiative for Cardiovascular Health Research in Developing Countries, New Delhi, India;
††Indian Council of Medical Research, New Delhi, India;
‡‡Public Health Foundation of India, New Delhi, India;
§§Department of Pediatrics, Sitaram Bhartiya Institute for Science and Research, New Delhi, India
p
p
s
u
r
r
1
f
l
M
S
h
2
D
aI ndia has one of the highest burdens of cardiovas-cular disease (CVD) worldwide. The annualnumber of deaths from CVD in India is pro-
ected to rise from 2.26 million (1990) to 4.77 mil-
ion (2020) (1). Coronary heart disease prevalence
ates in India have been estimated over the past sev-
ral decades and have ranged from 1.6% to 7.4% in
ural populations and from 1% to 13.2% in urban
opulations (2).
The INTERHEART study showed that CVD risk
actors such as abdominal obesity, hypertension, and
iabetes are higher among Indians, even at young
ges, than among other ethnic groups (3). The preva-
ence rates of CVD risk factors have been rapidly ris-
ng within India over the past 25 years, particularly
ithin urban communities (4). The reasons for this
igh burden of risk factors are speculative and have
een poorly investigated. In this regard, cohort studies provide unbiased estimates of the relationship of ex-
osure to outcomes, which would increase under-
tanding of the determinants of CVD.
The New Delhi Birth Cohort (5) provides a
nique opportunity to evaluate the incidence of CVD
isk factors in a young, urban Indian population. We
eport here the incidence of CVD risk factors in
,100 members of the cohort across a 7-year period
rom a mean age of 29 to 36 years and factors at base-
ine that were associated with increased risk.
ethods
tudy cohort. Details of the New Delhi Birth Co-
ort have been published elsewhere (5). Briefly,
0,755 married women of reproductive age in South
elhi participated in a study of pregnancy outcomes
nd childhood growth from 1969 to 1972. Over that
eriod, trained personnel recorded the weight and
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infants were followed at ages 3, 6, 9, and 12 months and
thereafter at 6-month intervals until 1973 (end of phase 1).
In the first 4 phases, which were conducted during 1969 to
1990, only anthropometric and survey data were collected.
In phase 5 (1998 to 2002), data on CVD risk factors were
collected to assess their relationship to birth and early life
anthropometry (5,6).
By the fifth phase, the number of participants had de-
reased to 1,526 owing to attrition, loss to follow-up, and
unicipal closure of unauthorized housing at the begin-
ing of phase 2 (which began in 1974 and concluded in
980). Loss to follow-up between phases 5 and 6 was mini-
ized through the following algorithm until all nonre-
ponders were accounted for: telephone calls/e-mails, house
isits, meeting with neighbors, and contact with local post
ffices. Failure to locate a participant occurred for 3.5% of
hase 5 participants. Reasons for nonparticipation included
ot attending follow-up despite agreeing to follow-up
9.0% of phase 5 participants), moving away from New
elhi (5.8%), refusal (3.9%), “busy schedule” (2.8%), and
eath (1.2%). Other reasons that occurred in fewer than
% of participants were ill/bedridden (0.9%), pregnancy/
aring for infant (0.4%), substance abuse (0.1%), fear of
lood collection (0.1%), in prison (0.1%), and family un-
illing (0.1%) (Fig. 1).
The initial cohort had a literacy rate of 85.1% (national
mean 33.7%). Hindus comprised the majority (84.3%),
with Sikhs, Christians, Muslims, and Jains contributing to
the remainder of the sample (11.6%, 2.1%, 1.1%, and
0.7%, respectively). Although the families had a higher
income than the national mean, many lived in 1-room ten-
ements (43%).
The ethics committee from the All India Institute of
Medical Sciences approved the study. Informed consent
was obtained from each participant.
Current phase of study. In the latest phase (phase 6),
from 2006 to 2009, 1,100 (72%) of the phase 5 partici-
pants consented to participate. Home visits were performed
by trained personnel to obtain informed consent and to
record information about the participants’ medical history,
family medical history, medication use, material posses-
sions, tobacco use, and alcohol consumption. Study per-
sonnel measured the participants’ blood pressure (Omron
7070, Bannockburn, Illinois), weight, height, and waist (and hip circumferences according to standardized tech-
niques (6).
Standard glucose tolerance tests (World Health Organi-
zation [WHO] protocol) were administered using a 75-g
anhydrous glucose load. Plasma glucose concentrations
were measured 120 min after the glucose challenge. Fasting
plasma glucose, cholesterol, and triglyceride levels were
analyzed by enzymatic methods (GOD-PAP, Randox Lab-
oratories Ltd., Crumlin, United Kingdom) with a Beckman
auto analyzer; high-density lipoprotein (HDL) cholesterol
was measured in the same manner after phosphotungstate
precipitation.
Definitions. Education was recorded as one of 7 catego-
ries from “no schooling” (category 1) through “professional
degree” (e.g., Master’s degree, PhD, medical qualification).
Intake of salt (added to cooked food), fruit, raw vegeta-
bles, and cooked vegetables was recorded using a food fre-
quency questionnaire and was divided into 8 frequency
categories (never, sometimes, once per month, twice per
month, once per week, 3 times per week, once daily, and
wice daily).
Overweight was defined by using both the WHO crite-
ion (body mass index [BMI] 25 kg/m2) and the Interna-
tional Obesity Task Force criterion for Asians (BMI 23
kg/m2) (7). Obesity was defined as BMI 30 kg/m2, as
recommended by WHO (8). Central obesity was defined as
a waist circumference 90 cm for men and 80 cm for
omen, as recommended for South Asians by the Interna-
ional Diabetes Federation (9).
Pre-hypertension was defined as a systolic blood pressure
f 120 to 139 mm Hg or diastolic blood pressure of 80 to
9 mm Hg. Hypertension was defined as a systolic blood
ressure of 140 mm Hg, a diastolic pressure of 90 mm
g, or being on drug treatment for hypertension.
Metabolic syndrome was defined by the presence of cen-
ral obesity and at least 2 of the following: 1) triglycerides
150 mg/dl (or drug therapy for lipids); 2) HDL choles-
erol 40 mg/dl for men and 50 mg/dl for women; 3)
lood pressure 130/85 mm Hg (or drug therapy for hy-
ertension); and 4) fasting plasma glucose 100 mg/dl, per
he International Diabetes Federation (9). Diabetes melli-
us was defined as a fasting plasma glucose concentration
126 mg/dl (7.0 mmol/l) or 120-min concentration of
200 mg/dl (11.1 mmol/l). Impaired glucose toleranceIGT) was defined as a fasting glucose 110 mg/dl (6.1
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(1998 – 2002)
N=1526
Did not attend follow-up despite agreeing to follow-up and 
repeated contacts to follow-up
n= 137
(9.0%) 
Moved away from Delhi
n=88
(5.8%)
Other reasons given for not participating:
n=69
(4.5%)
Busy schedule (2.8%)
Ill/bed-ridden (0.9%)
Pregnancy/caring for infant (0.4%) 
Substance abuse (0.1%)
Fear of blood collection (0.1%)
In prison (0.1%)
Family not willing (0.1%)
Refused follow-up
n=60
(3.9%)
Unable to locate
n=54
(3.5%)
Died
n=18
(1.2%)
Phase 6
(2006 – 2009)
N=1100
(72.1%)
Figure 1 New Delhi Birth Cohort Flow Diagram
Flow diagram of reasons for loss to follow-up between phases 5 and 6.
i
T
m
g
T
n
t
h
2
m
a
p
d
m
S
m
i
p
t
t
v
M
6
m
p
t
o
R
T
6
m
p
s
d
m
p
s
S
b
f
s
p
l
t
d
p
H
t
p
1768 Huffman et al. JACC Vol. 57, No. 17, 2011
Incidence of Cardiovascular Risk Factors in India April 26, 2011:1765–74mmol/l) or 120-min concentration of 140 mg/dl (7.8
mmol/l) in participants without diabetes (10).
Alcohol consumption was recorded as the frequency of
ntake and quantity of spirits, beer, and wine per week.
hese data were converted into units of alcohol (1 U  25
l of spirits, 282 ml of beer, or 125 ml of wine) and cate-
orized as none, 7 U, 7 to 14 U, and 14 U/week (6).
obacco (smoking and nonsmoking) use was defined as
ever, past, and current users.
Information on material possessions was recorded; par-
icipants were given a score of 1 or 0 for each of 17 house-
old items (electricity, fan, cycle, radio, motorized
-wheeler, gas stove, television, cable television, electric
ixer, electric grinder, electric air cooler, washing machine,
ir conditioner, home computer, TV dish antenna, tele-
hone) and car. This information was used to create a score
erived as the first principal component from a correlation
atrix of the 17 binary variables (11).
tatistical analysis. Continuous variables are reported as
ean  SD, or if skewed in distribution, as medians with
nterquartile ranges. Categoric variables are reported as pro-
ortions (%). We compared phase 5 measurements be-
ween participants and nonparticipants of phase 6 for sensi-
ivity analysis of nonparticipants. We compared continuous
ariables using paired t tests and categoric variables using
cNemar tests for participants seen in both phases 5 and
. We used multiple logistic regression to assess the deter-
Continuous Anthropometric and CVD Risk Factor Variables at PhTable 1 Continuous Anthropometric and CVD Risk Factor Va
Men
Phase 5 (n  652) P
Age, yrs 29.1 1.3
BMI, kg/m2 24.9 4.2
Waist circumference, cm 90.3 11.8
Hip circumference, cm 97.7 8.2
Waist/hip ratio 0.92 0.06
SBP, mm Hg 118.8 11.1
DBP, mm Hg 77.8 10.0
Fasting plasma glucose, mg/dl 98.8 20.6
120-min glucose, mg/dl 107.5 (91.4, 127.1) 1
Total cholesterol, mg/dl 198.4 43.6
Calculated LDL cholesterol, mg/dl 122.1 35.7
HDL cholesterol, mg/dl 44.4 11.0
Triglycerides, mg/dl 131.0 (95.0, 198.0) 1
Data are presented as mean  SD or median values (25th, 75th percentile). All differences f
unless noted ().
BMI  body mass index; CVD  cardiovascular disease; DBP  diastolic blood pressure; HDL  hiinants of changes in incident binary outcomes between
hases 5 and 6. The principal component analysis score was
ransformed into a Fisher-Yates normal score with a mean
f 0 and SD of 1 because it was skewed in distribution.
esults
he mean follow-up period between phases 5 and 6 was
.9  1.0 years (range 4.0 to 10.2 years). Participants had a
ean age of 29  1 years in phase 5 and 36  1 years in
hase 6 (Table 1). Ownership of 2-wheeler (81.3%), televi-
ion (99.6%), and gas stove (98.6%), largely reflecting mid-
le-class status, was common in phase 6 participants. Other
aterial possessions, such as car (45.0%) and home com-
uter (17.5%), were owned by fewer than one-half of re-
pondents.
ensitivity analysis. There were no significant differences
etween phase 6 participants and nonparticipants for the
ollowing phase 5 variables: sex, BMI, hip circumference,
ystolic blood pressure, diastolic blood pressure, fasting and
ost-load glucose, and low-density lipoprotein (LDL) cho-
esterol or in the proportions of overweight, obesity, hyper-
ension, IGT, and diabetes. However, we observed certain
ifferences: as compared with phase 6 male nonpartici-
ants, phase 5 age was 0.3 years younger (p  0.005) and
DL cholesterol (p  0.027) was 2.0 mg/dl lower in par-
icipants; as compared with phase 6 female nonparticipants,
hase 5 waist circumference, waist-to-hip ratio (WHR),
5 and 6 of the New Delhi Birth Cohorts at Phases 5 and 6 of the New Delhi Birth Cohort
Women
6 (n  652) Phase 5 (n  448) Phase 6 (n  448)
1 1.1 29.2 1.3 36.1 1.0
7 4.6 24.8 5.0 27.3 5.2
1 11.7 80.4 12.1 86.8 12.0
2 8.2 97.4 10.1 101.4 10.2
6 0.06 0.82 0.07 0.85 0.07
4 14.7 106.9 11.1 118.7 13.3
9 10.7 73.7 9.1 77.0 9.8
2 25.9 96.3 15.2 96.3 17.2
6.4, 129.6) 111.5 (96.4, 129.6) 114.0 (99.0, 132.0)
5 40.3 185.2 37.2 190.8 36.0
7 41.2 115.8 33.8 116.8 32.7
4 8.6 49.0 11.6 51.6 10.4
05.0, 199.0) 94.0 (71.0, 122.0) 99.0 (79.0, 136.0)
in-sex comparisons between participants seen in phases 5 and 6 are statistically significant,asesriable
hase
36.
26.
96.
100.
0.9
130.
82.
102.
11.5 (9
203.
122.
46.
41.5 (1
or withgh-density lipoprotein; LDL  low-density lipoprotein; SBP  systolic blood pressure.
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0.015), and 6.3 mg/dl (p  0.04) lower in participants.
Anthropometry. The annual incidence of obesity was
2.0% (95% confidence interval [CI]: 1.6% to 2.4%) for
men and 2.2% (95% CI: 1.7% to 2.8%) for women
(Table 2). Mean BMI, waist circumference, hip circum-
ference, and WHR (Table 1) and the prevalence of over-
weight, obesity, and central obesity (Figs. 2A and 2B) all
increased significantly in both men and women between
phases 5 and 6 (p  0.05). Mean BMI increased from 25
to 27 kg/m2 in both men and women (Table 1), resulting
in an increase in obesity from 9% to 21% in men and from
13% to 25% in women (Figs. 2A and 2B). Waist circum-
ference rose from a mean of 90 to 96 cm in men and from
80 to 87 cm in women (Table 1), resulting in an increase in
central obesity from 52% to 71% in men and from 48% to
70% in women (Figs. 2A and 2B).
After controlling for age and sex, multivariate logistic
regression analysis demonstrated significant positive associ-
ations between phase 5 BMI, waist circumference, WHR,
socioeconomic status (by principal component analysis
z-score), total cholesterol, and triglycerides and incident
obesity (Table 3). There was a significant inverse associa-
tion with tobacco use.
Hypertension. The annual incidence of hypertension was
4.2% (95% CI: 3.7% to 4.8%) for men and 1.8% (95%
CI: 1.3% to 2.3%) for women (Table 2). Mean systolic
blood pressure rose from 119 to 130 mm Hg in men and
from 107 to 119 mm Hg in women (Table 1). There were
similar increases in diastolic pressure. The prevalence of
hypertension rose from 11% to 34% in men and from 5%
Incidence Rates of Obesity, Hypertension,and Diab tes Over 6.9 Years of Follow-Upi th New Delhi Birth Cohort
Table 2
Incidence Rate f Ob sity, Hypertension,
and Diabetes Over 6.9 Years of Follow-Up
in the New Delhi Birth Cohort
Incident Cases/
At-Risk Sample
Annual Incidence
(Incidence/6.9 Yrs)
Obesity
Men 82 of 588 2.0% (95% CI: 1.6%–2.4%)
Women 60 of 386 2.2% (95% CI: 1.7%–2.8%)
Hypertension
Men 168 of 574 4.2% (95% CI: 3.7%–4.8%)
Women 52 of 419 1.8% (95% CI: 1.3%–2.3%)
Diabetes
Men 43 of 595 1.0% (95% CI: 0.8%–1.4%)
Women 15 of 412 0.5% (95% CI: 0.3%–0.9%)CI  confidence interval.to 15% in women (Figs. 2A and 2B). All of these changes
were statistically significant. Antihypertensive drug therapy
was reported in 6% of phase 6 respondents. After control-
ling for age and sex, multivariate logistic regression analysis
demonstrated significant positive associations between
phase 5 BMI, waist circumference, WHR, alcohol use, fam-
ily history of hypertension, total cholesterol, and triglycer-
ides and incident hypertension (Table 3).
IGT and diabetes mellitus. The annual incidence for
diabetes was 1.0% (95% CI: 0.8% to 1.4%) for men and
0.5% (95% CI: 0.3% to 0.9%) for women (Table 2).
Mean fasting glucose concentration increased significantly
in men but not in women (Table 1), whereas 120-min glu-
cose concentrations did not increase in men or women.
There was a significant increase in the prevalence of IGT in
women between phases 5 and 6, rising from 10% to 14%
(Fig. 2B), whereas the prevalence of diabetes doubled (ris-
ing from 5% to 12% in men and from 3.5% to 7% in
women). Antidiabetic drug therapy was reported in only
1.5% of phase 6 respondents.
After controlling for age and sex, multivariate logistic
regression analysis demonstrated significant positive associ-
ations between phase 5 BMI, waist circumference, WHR,
total cholesterol, and triglycerides and incident diabetes
(Table 3).
Total, LDL, and HDL cholesterol and triglycerides.
Total cholesterol increased by 5.1 mg/dl in men (p  0.05)
and 5.6 mg/dl in women (p  0.05). The LDL cholesterol
did not change in men or women, and HDL cholesterol
increased by 2.0 mg/dl in men and 2.6 mg/dl in women
(p  0.05). Triglycerides increased by 10.5 mg/dl in men
and 5.0 mg/dl in women (p  0.05) (Table 1). However,
lipid-lowering therapy was reported in 1.2% of phase 6
respondents.
Discussion
These are among the first cohort data to evaluate the inci-
dence of CVD risk factors in India. Both the incidence and
prevalence of risk factors are high at a young age in this
urban Indian population that is rapidly transitioning. The
incidence rate of obesity was higher in women compared
with men in the New Delhi Birth Cohort, but the inci-
dence rates of hypertension and diabetes were higher in
men. Central obesity, as measured by waist circumference,
appeared to be increasing in both men and women, with a
commensurate increase in WHR. Comparing phase 5 and
1770 Huffman et al. JACC Vol. 57, No. 17, 2011
Incidence of Cardiovascular Risk Factors in India April 26, 2011:1765–74Figure 2 New Delhi Birth Cohort CVD Risk Factors
(A) Categoric anthropometric and cardiovascular disease (CVD) risk factor variable prevalence (with 95% confidence intervals [CIs]) at phases 5 (red bars) and 6
(black bars) in men from the New Delhi Birth Cohort. All differences for within-sex comparisons between participants seen in phases 5 and 6 are statistically sig-
nificant unless noted (**). (B) Categoric anthropometric and CVD risk factor variable prevalence (with 95% CIs) at phases 5 and 6 in women from the New Delhi
Birth Cohort. All differences for within-sex comparisons between participants seen in phases 5 and 6 are statistically significant unless noted (**). BMI  body
mass index; DM  diabetes mellitus; HDL  high-density lipoprotein cholesterol; IGT  impaired glucose tolerance; TC  total cholesterol; TG  triglycerides.
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both men and women.
Participants in the New Delhi Birth Cohort were in the
middle to upper range of education and income relative to
other people within India. At the time the cohort started,
the majority lived in 1 room, which is an indication of the
difference in living standards between high-income coun-
tries and India at the time. This cohort appeared to remain
in the same class from 1969 to 2009 based upon a principal
component analysis of material possessions, which esti-
mates household socioeconomic position. However, com-
pared with respondents in the National Family Health Sur-
vey in India, the New Delhi Birth Cohort participants
represent the 2 highest wealth quintiles in India (4,11,12).
he participants live in much more spacious dwellings
ow, and it is an indication of the transitions that have
ccurred in India over the last 50 years that participants
ould be more recognizably “middle class” in terms of their
iving standards to a Western observer. Although our data
ay not necessarily be extrapolated to other parts and other
ges in India, especially rural India, this rapid increase in
VD risk factors may reflect the huge transitions in wealth
nd lifestyle occurring in other fast-growing cities in low-
nd middle-income countries.
These high rates impose a huge economic burden on the
Multivariate Logistic Regression Analyses for Predictors of ObesTable 3 Multivariate Logistic Regression Analyses for Predic
Phase 5 Variable (Unit) Phase 6 Obesity (BMI >30 kg/m2)
BMI (1 kg/m2) 2.07 (1.84–2.34)*
Waist circumference (1 cm) 1.18 (1.15–1.22)*
Waist/hip ratio (0.01) 1.13 (1.10–1.17)*
Alcohol† 0.84 (0.67–1.06)
Tobacco use (never, former, current) 0.73 (0.54–0.97)*
SES (possessions)‡ 1.23 (1.02–1.48)*
SES (education)§ 1.10 (0.95–1.28)
Add salt 0.94 (0.84–1.04)
Fresh fruit 1.06 (0.95–1.17)
Raw vegetables 1.09 (0.99–1.21)
Cooked vegetables 1.10 (0.97–1.23)
Total cholesterol (50 mg/dl) 1.23 (1.00–1.52)*
LDL cholesterol (10 mg/dl) 1.04 (0.99–1.09)
HDL cholesterol (10 mg/dl) 0.97 (0.82–1.15)
Triglycerides (log) 1.61 (1.12–2.32)*
Data are presented as odds ratio (95% confidence interval). Each cell represents a separate re
and 6, and sex. *p 0.05. Lifestyle factors: †alcohol consumption (4 levels from none to heav
‡socioeconomic status (SES) in adult life derived from possessions (normalized score based on
professional degree), food intake (8 levels from none to twice daily), and family history of an
Abbreviations as in Table 1.ountry as well as upon individuals. For example, the po- itential economic burden of increased diabetes prevalence in
India is considerable because estimated annual costs for
diabetes care (approximately 5,000 rupees in 2005 [13]) are
ising and now range from 5% to 34% of personal income in
ndia (14). Lower-income groups spend a greater proportion
f their income on diabetes care than higher-income groups,
urther aggravating disparities that impact the social determi-
ants of health.
omparison with other Indian populations. Figure 3
ompares the prevalence rates of overweight, hypertension,
nd diabetes in phase 6 of the New Delhi Birth Cohort
ith other prevalence studies in urban India for which the
articipants would be eligible, as described in a WHO In-
ia-sponsored systematic review on chronic diseases (4). All
curves increased over time, particularly after 2000. Our
ata represent the leading edge of the CVD risk factor bur-
en in young, urban India.
Extrapolation of risk factor trends in urban India also
rovide context for our data. Secular trends of overweight
BMI 25 kg/m2) and hypertension prevalence from the
aipur Heart Watch between 1993 and 2005 demonstrated
significant increase in the prevalence of both risk factors
15,16). Overweight prevalence in adults 30 to 39 years
ncreased from 20.7% to 33% in men and from 19.9% to
9.4% in women over 12 years of follow-up, an annual
ypertension, and Diabetes at Phase 6of Obesity, Hypertension, and Diabetes at Phase 6
hase 6 Hypertension (BP >140/90 mm Hg) Phase 6 Diabetes Mellitus
1.10 (1.06–1.14)* 1.12 (1.06–1.18)*
1.04 (1.03–1.06)* 1.04 (1.02–1.06)*
1.05 (1.02–1.07)* 1.09 (1.04–1.13)*
1.41 (1.20–1.65)* 1.00 (0.75–1.33)
1.20 (0.99–1.45) 1.00 (0.71–1.42)
1.07 (0.92–1.26) 0.97 (0.74–1.28)
0.99 (0.88–1.12) 0.92 (0.75–1.12)
1.02 (0.95–1.11) 1.00 (0.87–1.16)
1.01 (0.93–1.10) 0.93 (0.82–1.07)
1.06 (0.98–1.15) 0.98 (0.86–1.12)
1.00 (0.91–1.10) 0.93 (0.80–1.09)
1.44 (1.19–1.75)* 1.40 (1.04–1.89)*
1.05 (1.00–1.09)* 1.04 (0.96–1.12)
1.02 (0.89–1.18) 0.89 (0.69–1.14)
2.26 (1.64–3.12)* 2.87 (1.72–4.79)*
n model. All analyses were adjusted for age at baseline, difference in age between phases 5
on number of units per week), tobacco use (categorized into never, ex-user, and current user),
al components analysis), §SES in adult life based on education (7 levels from no schooling to
h blood pressure, angina, myocardial infarction, stroke, or diabetes in a first-degree relative.ity, Htors
P
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2009 (end of follow-up for phase 6 of the New Delhi Birth
Cohort), the obesity prevalence rates in the Jaipur Heart
Watch would be 36.6% for men and 43.4% for women
(compared with 64.7% and 65.1% in the New Delhi Birth
Cohort).
The overall adult prevalence of hypertension in the Jaipur
Heart Watch increased from 20.4% to 41.4% in men and
from 15.2% to 34.9% in women over 12 years of follow-up,
an annual increase in prevalence of 1.8% in men and 1.6% in
women (15). If these increases continued at the same rate
from 2005 to 2009 (end of follow-up for phase 6 of the
New Delhi Birth Cohort), the hypertension prevalence
rates in the Jaipur Heart Watch would be 48.6% for men
and 41.5% for women (compared with 34% and 15% in
the New Delhi Birth Cohort).
In the Chennai Urban Population Study (1997 to
2005), the prevalence rate of diabetes increased from 12%
Figure 3 Risk Factor Trends in India
Temporal trends of the prevalence of overweight (green line), hypertension (blue li
Each star represents the New Delhi Birth Cohort prevalence data during phaseto 18.3% over 8 years (0.8% annual incidence); however, lthis cohort had a 47% loss to follow-up (17). If this in-
rease continued at the same rate from 2005 to 2009 (end
f follow-up for phase 6 of the New Delhi Birth Cohort),
he diabetes prevalence rates in the Chennai Urban Popula-
ion Study would be 20.7% (compared with 8.4% in the
ew Delhi Birth Cohort). Similar estimates have been re-
orted through secular trends from another study in south-
rn India (18), although our participants were 4 to 5 years
ounger.
Ramachandran et al. (19) recently reported an overall
ncrease in the prevalence of diabetes in urban India
rom 5% (1985) to 18.6% (2006). Another report by
han et al. (20) estimated an increase in diabetes preva-
ence from 3% (1979) to 7.3% (2005) throughout urban
ndia; however, the 2005 estimates were based upon
elf-reporting (21).
easons for CVD risk factor increases. The causes of
hese incidence rates of CVD risk factors are complex but
d diabetes (orange line) in urban India (diagnosis based on laboratory testing).
ta from World Health Organization (WHO) India (4).ne), an
6. Daikely include lifestyle changes associated with urbanization
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company economic development (22). We speculate that
increased urban and socioeconomic development in New
Delhi over the duration of this cohort was broadly associ-
ated with increased caloric intake (particularly of energy-
dense foods) and decreased physical activity.
The high rates of metabolic disturbances—central obe-
sity, hypertension, dyslipidemia, IGT, and diabetes
mellitus—may also be related to abnormal life-course
events, such as maternal undernutrition, low birth weight,
and subsequent adiposity rebound (5). Lower weight in
infancy, and greater childhood and adolescent BMI or BMI
gain have previously been shown to be associated with an
increased risk of adult hypertension, IGT, and diabetes in
this cohort (23).
tudy strengths/limitations. This cohort provides pro-
pective incidence data of key CVD risk factors such as
besity, hypertension, and diabetes in India. Standardized
ollection of questionnaire, anthropometric, and blood
ressure data are strengths of this cohort, as well as the lon-
itudinal follow-up since 1969. The main strengths of the
tudy were the standardized anthropometric and biochemi-
al risk factor measurements and detailed characterization
f lifestyle factors, recorded using identical methods at both
ime points.
However, there are important limitations to these find-
ngs. The sample size was fairly small with a relatively nar-
ow age range, which limits the generalizability of our find-
ngs. The cohort is composed of participants originally
rom South Delhi, an upper middle-class urban neighbor-
ood, which cannot represent all the different populations
f India, particularly rural populations. There were minor
ifferences in selected phase 5 risk factors between partici-
ants and nonparticipants, which may have biased the re-
ults. However, these differences may lead to underesti-
ates of risk factor incidence. Finally, these data reflect
ncidence for CVD risk factors, which may or may not lead
o CVD events; however, risk factors such as diabetes con-
er risk for other competing problems such as blindness and
enal failure.
mplications. The high incident rates of obesity, hyper-
ension, and diabetes in this young, urban Indian cohort
re likely to lead to a high burden of CVD in this popula-
ion in the future. The remarkable changes in prevalence
ates of these risk factors over such a short span of time in
his young, urban cohort could have implications for these of appropriate risk screening and intervention strategies
eginning at younger ages. We believe that a life-course
pproach should be emphasized, specifically one that in-
ludes health promotion during childhood and adoles-
ence, primary prevention for individuals with CVD risk
actors, and secondary prevention for those with established
oronary heart disease and stroke.
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